A randomized comparison of target-controlled propofol infusion and patient-controlled sedation during ERCP

Background and study aims: Propofol is widely used during endoscopic retrograde cholangiopancreatography (ERCP) but high doses are recognized as a risk factor for sedation-related complications. The aim of this study was to compare target-controlled infusion (TCI) with patient self-administration (patient-controlled sedation, PCS) of propofol during ERCP. Propofol consumption, the ease of ERCP performance, and speed of recovery were recorded.

Patients and methods: A total of 82 patients undergoing elective ERCP were randomized 1:1 to receive propofol 10 mg/mL using TCI (initial targeted effect-site concentration 2 μg/mL) or PCS (single bolus 1 mL, lockout time set at zero). Alfentanil was administered if signs of insufficient analgesia occurred. Consumption of propofol and alfentanil was recorded, sedation levels and vital signs were monitored, the ease of ERCP performance, speed of recovery, and satisfaction with sedation were evaluated.

Results: All procedures were performed without interruptions or major sedation-related complications. The mean (± SD) consumption of propofol was 306 ± 124 mg in the TCI group and 224 ± 101 mg in the PCS group (P = 0.002). Patients in the PCS group recovered faster (P = 0.035). The mean (± SD) consumption of alfentanil was 0.5 ± 0.4 mg in both groups. The combination of propofol and alfentanil was associated with an increased risk of sedation-related adverse events (P = 0.031).

Conclusions: No benefits of TCI over PCS could be demonstrated in this study. We recommend considering PCS as a feasible option for propofol administration during ERCP because of its ease of use, high success rate, reduced consumption of propofol, and faster recovery.

• References

• 1 Wehrmann T, Kokabpick S, Lembcke B et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc 1999; 49: 677-683
• 2 Bo LL, Bai Y, Bian JJ et al. Propofol vs traditional sedative agents for endoscopic retrograde cholangiopancreatography: a meta-analysis. World J Gastroenterol 2011; 17: 3538-3543
• 3 Garewal D, Powell S, Milan SJ et al. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev 2012; 6 CD007274
• 4 Wehrmann T, Riphaus A. Sedation with propofol for interventional endoscopic procedures: a risk factor analysis. Scand J Gastroenterol 2008; 43: 368-374
• 5 Newson C, Joshi GP, Victory R et al. Comparison of propofol administration techniques for sedation during monitored anesthesia care. Anesth Analg 1995; 81: 486-491
• 6 Russell D. Intravenous anaesthesia: manual infusion schemes versus TCI systems. Anaesthesia 1998; 53: 42-45
• 7 Fanti L, Agostoni M, Arcidiacono PG et al. Target-controlled infusion during monitored anesthesia care in patients undergoing EUS: propofol alone versus midazolam plus propofol. A prospective double-blind randomised controlled trial. Dig Liver Dis 2007; 39: 81-86
• 8 Agostoni M, Fanti L, Gemma M et al. Adverse events during monitored anesthesia care for GI endoscopy: an 8-year experience. Gastrointest Endosc 2011; 74: 266-275
• 9 Mazanikov M, Udd M, Kylänpää L et al. Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled study. Gastrointest Endosc 2011; 73: 260-266
• 10 Mazanikov M, Udd M, Kylänpää L et al. Patient-controlled sedation for ERCP: a randomized double-blind comparison of alfentanil and remifentanil. Endoscopy 2012; 44: 487-492
• 11 Mazanikov M, Udd M, Kylänpää L et al. Dexmedetomidine impairs success of patient-controlled sedation in alcoholics during ERCP: a randomized, double-blind, placebo-controlled study. Surg Endosc 2013; 27: 2163-2168
• 12 Schnider TW, Minto CF, Shafer SL et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-1516
• 13 Manyam SC, Gupta DK, Johnson KB et al. When is a bispectral index of 60 too low? rational processed electroencephalographic targets are dependent on the sedative-opioid ratio. Anesthesiology 2007; 106: 472-483
• 14 Gillham MJ, Hutchinson RC, Carter R et al. Patient-maintained sedation for ERCP with a target-controlled infusion of propofol: a pilot study. Gastrointest Endosc 2001; 54: 14-17
• 15 Chutkan RK, Ahmad AS, Cohen J et al. ERCP core curriculum. Gastrointest Endosc 2006; 63: 361-376
• 16 Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth 1995; 7: 89-91
• 17 Alhashemi JA, Kaki AM. Anesthesiologist-controlled versus patient-controlled propofol sedation for shockwave lithotripsy. Can J Anaesth 2006; 53: 449-455
• 18 Oei-Lim VL, Kalkman CJ, Makkes PC et al. Patient-controlled versus anesthesiologist-controlled conscious sedation with propofol for dental treatment in anxious patients. Anesth Analg 1998; 86: 967-972
• 19 Maslekar S, Balaji P, Gardiner A et al. Randomized controlled trial of patient-controlled sedation for colonoscopy: Entonox vs modified patient-maintained target-controlled propofol. Colorectal Dis 2011; 13: 48-57
• 20 Fanti L, Agostoni M, Casati A et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc 2004; 60: 361-366
• 21 Pavlin DJ, Coda B, Shen DD et al. Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. Anesthesiology 1996; 84: 23-37